What is he best known for?
The fields of study he is best known for:
- Enzyme
- Gene
- Internal medicine
His primary areas of investigation include Internal medicine, Endocrinology, Galanin, Neuropeptide and Receptor.
Tamas Bartfai interconnects NMDA receptor, Interleukin, Proinflammatory cytokine and Receptor antagonist in the investigation of issues within Endocrinology.
His study of Galanin receptor is a part of Galanin.
He combines subjects such as Neuroscience, Withdrawal reflex and Neurotransmitter with his study of Neuropeptide.
His Receptor study incorporates themes from Biological activity, Gene expression and Binding site.
His studies deal with areas such as Amyloid precursor protein and Cell biology as well as Biochemistry.
His most cited work include:
- The role of inflammation in epilepsy (977 citations)
- Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases (673 citations)
- Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. (525 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Galanin, Receptor and Neuropeptide.
His research brings together the fields of Spinal cord and Internal medicine.
His Endocrinology research incorporates themes from Agonist and Muscarinic acetylcholine receptor.
His Galanin research is mostly focused on the topic Galanin receptor.
Tamas Bartfai has researched Receptor in several fields, including Molecular biology, Pharmacology and Cell biology.
The Neuropeptide study combines topics in areas such as Locus coeruleus and Nociception.
He most often published in these fields:
- Internal medicine (44.66%)
- Endocrinology (44.08%)
- Galanin (34.17%)
What were the highlights of his more recent work (between 2007-2021)?
- Receptor (27.57%)
- Endocrinology (44.08%)
- Internal medicine (44.66%)
In recent papers he was focusing on the following fields of study:
Receptor, Endocrinology, Internal medicine, Galanin and Neuropeptide are his primary areas of study.
The concepts of his Receptor study are interwoven with issues in Transcriptome, Pharmacology and Cell biology.
As part of the same scientific family, Tamas Bartfai usually focuses on Internal medicine, concentrating on Genetically modified mouse and intersecting with Dentate gyrus, Neuroinflammation and Downregulation and upregulation.
He studies Galanin, focusing on Galanin receptor in particular.
His Galanin receptor research is multidisciplinary, incorporating elements of Amino acid, Neurotransmission, GABAergic, Mood disorders and Disease.
His Neuropeptide study deals with Neuroscience intersecting with Long-term potentiation.
Between 2007 and 2021, his most popular works were:
- The role of inflammation in epilepsy (977 citations)
- A blood based 12-miRNA signature of Alzheimer disease patients (317 citations)
- IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures (245 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
The scientist’s investigation covers issues in Galanin, Receptor, Neuropeptide, Internal medicine and Endocrinology.
His biological study spans a wide range of topics, including Neuropeptide Y receptor, Pharmacology, Peptide and Cell biology.
His research in the fields of G protein-coupled receptor overlaps with other disciplines such as Ring size.
Particularly relevant to Galanin receptor is his body of work in Neuropeptide.
His studies link Diabetes mellitus with Internal medicine.
His research is interdisciplinary, bridging the disciplines of Kainic acid and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
